Artiva Biotherapeutics (ARTV) Shares Issued (2024 - 2026)

Artiva Biotherapeutics (ARTV) has 3 years of Shares Issued data on file, last reported at $608789.0 in Q1 2026.

• On a quarterly basis, Shares Issued fell 45.33% year-over-year to $608789.0 in Q1 2026; TTM through Mar 2026 was $608789.0, a 45.33% decrease from a year earlier, with the FY2025 full-year figure at $600000.0, changed N/A from the prior year.
• Shares Issued for Q1 2026 stood at $608789.0, up from $600000.0 in the prior quarter.
• Over the last five years, Shares Issued for ARTV reached as high as $1.4 million in Q3 2025 and fell as low as $600000.0 in Q4 2025.
• Historically, Shares Issued has averaged $986251.7 across 3 years, with a median of $1.1 million in 2024.
• Across the five-year window, Shares Issued advanced 27.48% in 2025 and slumped 45.33% in 2026, its largest moves.
• Year by year, Shares Issued stood at $1.1 million in 2024, then tumbled by 43.64% to $600000.0 in 2025, then rose by 1.46% to $608789.0 in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $608789.0 in Q1 2026, $600000.0 in Q4 2025, and $1.4 million in Q3 2025.